Condition: Oligometastatic Disease · Non-small Cell Lung Cancer · Driver Mutation · Sponsor: Tata Memorial Hospital
A Phase II randomized controlled trial of TKI Alone versus TKI and Local Consolidative Radiation Therapy in oncogene driver mutated oligo metastatic Non-small cell lung cancer patients.
This description comes directly from the study's public registry record.
Dr. Anil Tibdewal, MD · 91-22-24177000 · aniltibdewal@gmail.com
Dr. Jai Prakash Agarwal, MD · 91-22-24177000 · agarwaljp@tmc.gov.in
Always discuss trial participation with your own doctor first.
| Tata Memorial Hospital | Mumbai, Maharashtra, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05277844